Unibest

Pharmaceutical intermediates

Calcipotriol Intermediates

3 pharmaceutical intermediates for Calcipotriol. Indication: Psoriasis; Plaque psoriasis.

提交项目All intermediates

About Calcipotriol

Originator
Leo Pharmaceutical Products Ltd
Indication
Psoriasis; Plaque psoriasis
Approved Date
01/01/1990

Available intermediates

3 intermediates currently listed for Calcipotriol. Request specifications, documentation or a quotation for any item below.

Calcipotriol intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one112849-17-9//
Bis-TBDMS-trans-calcipotriol112849-27-1//
(5E)-Calcipotriene113082-99-8//

Other programs under C

Cabozantinib S-malateCalcitriolCamlipixantCanagliflozinCangrelor TetrasodiumCapivasertib Capmatinib HydrochlorideCarfilzomib

Building toward Calcipotriol?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →